Would it be better to shift the incentive to patients?

October 12, 2021 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

Would a system built from scratch today allow a dispensing decision to be set against the backdrop of an undisclosed financial incentive provided by a pharmaceutical company? …

Subscribe now to continue reading.

Latest Video

CSL Centenary Fellowships awarded to Australian scientists pioneering lifelong immunity and AI-designed proteins
October 29, 2025 - Australian Biotech
Australians with chronic disease call for stronger investment in PBS
October 29, 2025 - Latest News
Australian-based world-first RNA trial offers new hope for lupus patients
October 29, 2025 - Australian Biotech
Process as power - how our institutions defend policy decisions by making them untouchable truths
October 30, 2025 - Latest News
Medicines Australia welcomes new directors and reaffirms commitment to innovation and access
October 29, 2025 - Latest News

Would it be better to shift the incentive to patients?

This is a preview of subscriber content

Latest Video

Most Read

CSL Centenary Fellowships awarded to Australian scientists pioneering lifelong immunity and AI-designed proteins

Australians with chronic disease call for stronger investment in PBS

Australian-based world-first RNA trial offers new hope for lupus patients

Process as power - how our institutions defend policy decisions by making them untouchable truths

Medicines Australia welcomes new directors and reaffirms commitment to innovation and access

New Stories

The 'Dispatched' Week in Review Podcast - 31 October

Aroa Biosurgery appoints Paul Shearer to Board as John Pinion retires

Immuron provides update on U.S. clinical trials for Travelan and IMM-529

Firebrick Pharma launches new Nasodine Throat Spray for international markets

Amplia Therapeutics begins trading on U.S. OTCQB Venture Market

DHL Supply Chain opens New Zealand’s most advanced life sciences and healthcare logistics facility

The continued 'false framing' aims to make us feel guilty for wanting more on health

Sign In

Would it be better to shift the incentive to patients?

This is a preview of subscriber content

Latest Video

Most Read

CSL Centenary Fellowships awarded to Australian scientists pioneering lifelong immunity and AI-designed proteins

Australians with chronic disease call for stronger investment in PBS

Australian-based world-first RNA trial offers new hope for lupus patients

Process as power - how our institutions defend policy decisions by making them untouchable truths

Medicines Australia welcomes new directors and reaffirms commitment to innovation and access

Follow Us

New Stories

The 'Dispatched' Week in Review Podcast - 31 October

Aroa Biosurgery appoints Paul Shearer to Board as John Pinion retires

Immuron provides update on U.S. clinical trials for Travelan and IMM-529

Firebrick Pharma launches new Nasodine Throat Spray for international markets

Amplia Therapeutics begins trading on U.S. OTCQB Venture Market

DHL Supply Chain opens New Zealand’s most advanced life sciences and healthcare logistics facility

The continued 'false framing' aims to make us feel guilty for wanting more on health